Continuous positive airway pressure and surfactant; combined data from animal experiments and clinical trials

Biology of the Neonate

Volumn 81, Issue SUPPL. 1, 2002, Pages 16-19

  Thomson, Merran A ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Animals, newborn; Bronchopulmonary dysplasia; Continuous positive airway pressure; Infant, premature; Pulmonary surfactants; Respiratory distress syndrome

Indexed keywords

ARTIFICIAL LUNG SURFACTANT;

ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE MODEL; HUMAN; INFANT; LUNG ALVEOLUS; LUNG DYSPLASIA; LUNG VENTILATION; NEWBORN; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIMATE; PRIORITY JOURNAL; RISK FACTOR; SAFETY;

ANIMALIA; PRIMATES;

EID: 0036244802     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056766     Document Type: Conference Paper

References (16)

1. Lung mechanics during spontaneous ventilation in preterm and full term rabbit neonates
2. Bronchiolar epithelial lesions in the spontaneously breathing preterm newborn rabbit
3. Animal models of neonatal surfactant dysfunction
4. Ventilator induced lung injury
5. Artificial ventilation of preterm newborn rabbits; effects of positive end-expiratory pressure on lung mechanics and lung morphology
6. The effects of preterm delivery and mechanical ventilation on human lung growth
7. Decreased alveolarisation in baboon survivors with bronchopulmonary dysplasia
8. Neonatal chronic lung disease in extremely immature baboons
9. Continuous distending pressure
10. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers
11. Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in very preterm infants
12. Early treatment with nasal continuous positive airway pressure in very low birthweight infants
13. 'Minitouch' treatment of very low-birth-weight infants
14. Early treatment with nasal-CPAP
15. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome
16. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation